Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INPP5D: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
INPP5D is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, implicated in. Associated with Als, Alzheimer, Ms. Connected to 25 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | INPP5D |
| Full Name | Inositol Polyphosphate-5-Phosphatase D (SHIP1) |
| Aliases | SHIP1 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | hematopoietic cells and microglia |
| Molecular Weight | 145 kDa |
| Amino Acids | 1190 aa |
| Exons | 13 |
| Pathways | PI3K, mTOR, mtor, NF-κB |
| Ensembl ID | ENSG00000168918 |
| GeneCards | INPP5D |
| Human Protein Atlas | INPP5D |
| C2 domain | Mediates calcium-dependent membrane binding, facilitating SHIP1 localization to PI(3,4,5)P3-enriched membrane domains. |
| Substrate | Converts PI(3,4,5)P3 to PI(3,4)P2 through 5'-dephosphorylation |
| Signaling output | Reduces AKT activation, dampening cell survival, proliferation, and inflammatory signaling |
| Associated Diseases | Als, Alzheimer, Alzheimer's disease, cancer |
| Interactions | ABCA7, Actin, AD RISK GENES, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE |
| SciDEX Hypotheses | INPP5D (SHIP1) Inhibition to Shift Microglial Pola |
| KG Connections | 364 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
INPP5D["INPP5D"]
Alzheimer{"Alzheimer"}
INPP5D -->|"activates"| Alzheimer
Neurodegeneration{"Neurodegeneration"}
INPP5D -->|"activates"| Neurodegeneration
Als{"Als"}
INPP5D -->|"activates"| Als
Ms{"Ms"}
INPP5D -->|"activates"| Ms
APOE["APOE"]
INPP5D -->|"activates"| APOE
CYTOKINES["CYTOKINES"]
INPP5D -->|"activates"| CYTOKINES
PROINFLAMMATORY_CYTOKINES["PROINFLAMMATORY CYTOKINES"]
INPP5D -->|"activates"| PROINFLAMMATORY_CYTOKINES
RIPK1["RIPK1"]
INPP5D -->|"activates"| RIPK1
Mapk(["Mapk"])
INPP5D -->|"activates"| Mapk
Immune_Response(["Immune Response"])
INPP5D -->|"activates"| Immune_Response
neurodegeneration["neurodegeneration"]
INPP5D -->|"implicated in"| neurodegeneration
APP["APP"]
APP -->|"associated with"| INPP5D
GENES["GENES"]
GENES -->|"activates"| INPP5D
LGALS3["LGALS3"]
LGALS3 -->|"activates"| INPP5D
APOE4["APOE4"]
APOE4 -->|"activates"| INPP5D
NADK["NADK"]
NADK -->|"activates"| INPP5D
style INPP5D fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:INPP5D | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Late-Onset Alzheimer'S Disease | risk_factor_for | disease | 0.93 |
| MGnD-astrocyte cross-talk | inhibits | process | 0.89 |
| Mgnd Response | suppresses | process | 0.88 |
| Alzheimer'S Disease | associated_with | disease | 0.85 |
| Neuronal Loss | contributes_to | phenotype | 0.85 |
| Alzheimer's disease | associated_with | disease | 0.80 |
| Amyotrophic Lateral Sclerosis | risk_factor_for | disease | 0.75 |
| TREM2 downstream signaling | inhibits | pathway | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| OXIDATIVE PHOSPHORYLATION | causes | pathway | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| NLRP3 INFLAMMASOME | activates | pathway | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| ALZHEIMER'S DISEASE | interacts_with | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| APOE | loss_affects | entity | 0.60 |
| astrocyte | loss_affects | entity | 0.60 |
| ABI3 | associated_with | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| late-onset Alzheimer's disease | biomarker_for | disease | 0.60 |
| cancer | associated_with | disease | 0.60 |
| phagocytosis | implicated_in | process | 0.60 |
| MEF2C | interacts_with | gene | 0.60 |
| NME8 | interacts_with | gene | 0.60 |
| PICALM | interacts_with | gene | 0.60 |
| PTK2B | interacts_with | gene | 0.60 |
| RIN3 | interacts_with | gene | 0.60 |
| SLC24A4 | interacts_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:INPP5D | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| ITGB8-TGFβ signaling | upregulates | pathway | 0.90 |
| TIM-3 | interacts_with | protein | 0.80 |
| ALZHEIMER DISEASE | associated_with | gene | 0.80 |
| HLA | activates | gene | 0.70 |
| NEURODEGENERATION | regulates | disease | 0.65 |
| LGALS3 | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| PTK2B | associated_with | gene | 0.60 |
| LILRB2 | associated_with | gene | 0.60 |
| PLCG2 | associated_with | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | regulates | gene | 0.60 |
| GENETIC RISK LOCI | regulates | gene | 0.60 |
| CYTOKINES | regulates | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| AGING | regulates | gene | 0.60 |
| PROINFLAMMATORY CYTOKINES | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| NEUROINFLAMMATION | expressed_in | gene | 0.60 |
| NF-ΚB | expressed_in | gene | 0.60 |
| AMYLOID | expressed_in | gene | 0.60 |
| JAK | expressed_in | gene | 0.60 |
| IL-6 | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| MICROGLIA | interacts_with | gene | 0.60 |
| AD RISK GENES | interacts_with | gene | 0.60 |
| ITGB8 | activates | gene | 0.60 |
| ALZHEIMER DISEASE | activates | gene | 0.60 |
| TAU PATHOLOGY | activates | gene | 0.60 |
| NADK | activates | gene | 0.60 |
| STAT3 | expressed_in | gene | 0.60 |
| AKT | expressed_in | gene | 0.60 |
| TNF | expressed_in | gene | 0.60 |
| CD33 | interacts_with | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| GASDERMIN | regulates | gene | 0.60 |
| ROS | regulates | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| PLD3 | associated_with | gene | 0.60 |
| ABCA7 | associated_with | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| PICALM | associated_with | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| INPP5D (SHIP1) Inhibition to Shift Microglial Polarization | 0.758 | neurodegeneration | TREM2 agonism vs antagonism in DAM micro |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.862
neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.886
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] | Tsai AP, Martin AK, Mi A, Yeh AE, Ramire | Molecular neurodegeneration | 2026 | 0 |
| Single-cell sequencing analysis and machine learning model reveal aberrant TIM-3 [PMID:41580850] | Xu Z, Chen M, Liang F, Song S, Lei J et | J Transl Med | 2026 | 0 |
| Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammat [PMID:41633359] | Xie X, Liu J, Liang W, Zhang Y, Gong X e | Immunity | 2026 | 0 |
| INPP5D/SHIP1-mediated immunometabolic remodeling of renal monocytes in idiopathi [PMID:41853261] | Dai H, Liu B, Rui H, Yang L, Jiang H et | Front Immunol | 2026 | 0 |
| PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] | Tsai AP, Martin AK, Mi A, Yeh AE, Ramire | Mol Neurodegener | 2026 | 0 |
| SHIP-1 adapter functions mediate recruitment of FCRL1 to the BCR and inhibition [PMID:41968726] | Wolfe MM, Tallon Arranz R, Zenni EL, Wil | Immunohorizons | 2026 | 0 |
| Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammat [PMID:41633359] | Xie X, Liu J, Liang W, Zhang Y, Gong X, | Immunity | 2026 | 0 |
| Single-cell sequencing analysis and machine learning model reveal aberrant TIM-3 [PMID:41580850] | Xu Z, Chen M, Liang F, Song S, Lei J, Hu | Journal of translational medic | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.57 · 2026-04-01
Hypotheses and analyses mentioning INPP5D in their description or question text
No additional research found